Subtype-resolved norepinephrine imaging with an engineered α₁D-adrenergic receptor indicator

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Genetically encoded fluorescent indicators are crucial for measuring neuromodulator dynamics.
• Existing norepinephrine (NE) sensors utilize a restricted range of adrenergic receptor scaffolds.

Purpose of the Study:

• To engineer a novel NE indicator, Alpha1DLight, derived from the human α1D-adrenergic receptor.
• To characterize Alpha1DLight's performance and validate its utility in various biological systems.

Main Methods:

• Engineering of Alpha1DLight from the human α1D-adrenergic receptor.
• Characterization of NE-evoked responses, affinity, and kinetics in HEK293T cells.
• Pharmacological benchmarking against known α1D-AR ligand-response data.
• In vivo validation using fiber photometry in cultured neurons, brain slices, and behaving mice.

Main Results:

• Alpha1DLight exhibited large NE-evoked fluorescence responses (up to 612%) with nanomolar affinity (EC50 = 76 nM).
• The sensor demonstrated rapid activation (τON = 193 ms) and slow deactivation (τOFF = 6.75 s) without downstream signaling.
• Pharmacological profiling confirmed preservation of α1D-like ligand-response properties.
• Reversible NE signals were detected in vivo, correlating with arousal and optogenetic stimulation.

Conclusions:

• Alpha1DLight provides a subtype-informed approach for NE imaging, complementing existing sensors.
• This new indicator is suitable for studying sustained noradrenergic activity in the brain.
• The receptor-informed design supports advanced optical pharmacology for NE research.